Healthcare

Healthcare IT has been hailed as the solution to Australia's dual healthcare challenge of rising expenditure and an aging population. The adoption of efficient IT in the healthcare environment is a government driven mandate that is being received with mixed feelings among healthcare professionals. The current research explores healthcare IT spendin...

13 Mar 2015  |  Asia Pacific  |  Market Research

Analysis of the Global Vaccines Delivery Market

Innovative Technologies and Future Trends for Stakeholders

Infographics

×

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...

This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. ...

The Singapore private outpatient diagnostic imaging services market offers insights on diagnostic imaging products such as computed tomography scanners, magnetic resonance imaging, X-ray, mammogram, positron emission tomography, and single-photon emission computed tomography used in polyclinics, private hospitals, and diagnostic centers. Procedura...

24 Feb 2015  |  Asia Pacific  |  Market Research

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies

Infographics

×

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

Investments in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. Between 2007 and 2012, global investment in R&D in the industry took a detour from US and Europe towards Asia-Pacific (APAC) countries, primarily targeting Australia, Singapore, and South Korea. This research report pre...